Cigna and CVS shares fall as Trump targets – Business News
President Trump took goal at Big Pharma on Monday by signing an govt order meant to slash Americans’ prescription drug costs by up to 90% — sparking a selloff in firms he labeled as “middlemen.”
“What’s been happening is, we’ve been subsidizing other countries throughout the world,” Trump defined at a White House signing ceremony, calling the motion one of his “most important orders.”
“Some prescription drug and pharmaceutical prices will be reduced almost immediately by 50 to 80 to 90%,” he added.
President Trump on Monday signed a sweeping govt order geared toward decreasing drug costs. REUTERS
The coverage is a revival of Trump’s signature “most favored nation” drive from his first time period, with a new push to get international nations to tackle more of the analysis and development (R&D) prices that specialists say America has disproportionately shouldered.
Trump additionally reiterated his long-standing criticism of firms that own pharmacy benefit managers, like CVS and Cigna, for what he described as their function in distorting drug pricing.
“I would cut out the middlemen,” Trump mentioned.
“Everybody should equalize. Everybody should pay the same price.”
His remarks despatched shares of Cigna, one of the nation’s 5 largest health insurers, plunging almost 6%, whereas drugstore giant CVS Health, mother or father company of Aetna, sank more than 3%.
UnitedHealth Group, which owns OptumRx, dipped much less than 1%.
The US pays the best costs for pharmaceuticals, usually almost thrice more than different developed nations. The order provides drugmakers 30 days to decrease the costs of their medicines to align with what different nations pay.
Cigna, one of the nation’s 5 largest health insurers, noticed its stock fall almost 5%. Bloomberg by way of Getty Images
It directs US Trade Representative Jamieson Greer and Commerce Secretary Howard Lutnick to “take all appropriate action against unreasonable and discriminatory policies in foreign countries that suppress drug prices abroad,” White House officers mentioned.
After 30 days, Health and Human Services Secretary Robert F. Kennedy Jr. will “set clear targets for price reductions across all markets” within the US and open a “round of negotiations” with industry leaders.
Trump warned that failure to show “significant progress” within six months would set off additional authorities motion, together with the potential use of tariffs.
“If they don’t bring their prices down, we’re going to look at using every available tool,” Trump mentioned.
The govt order stopped short of specifying targets or detailing which medicine could be affected.
It additionally included language instructing businesses to contemplate permitting direct-to-consumer importation of medicine, as properly as restrictions on pharmaceutical exports — each of which might face legal hurdles.
CVS Health, mother or father company of Aetna, dropped about 3% during morning trading. Christopher Sadowski
“This order’s suggestion of broader or direct-to-consumer importation stretches well beyond what the statute allows,” warned Paul Kim, a health coverage lawyer.
Major US drugmakers initially noticed shares tumble on considerations over his “most favored nation” pricing plan, however the sector rebounded after analysts and legal specialists mentioned the manager order could be troublesome to implement.
“Importing foreign prices from socialist countries would be a bad deal for American patients and workers,” mentioned Stephen Ubl, CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA).
“It would mean less treatments and cures and would jeopardize the hundreds of billions our member companies are planning to invest in America.”
Ubl mentioned the true drivers of high drug prices embody “foreign countries not paying their fair share and middlemen driving up prices for US patients.”
Merck rose 5.9%, Pfizer gained 3.6%, Gilead climbed 7.1% and Eli Lilly was up 2.9%.
The directive additionally urges the Federal Trade Commission to step up enforcement towards what it calls anti-competitive practices by drugmakers, such as patent manipulation and offers to delay the release of generic options.
“I would cut out the middlemen,” Trump mentioned on the White House earlier than signing the order. REUTERS
“President Donald Trump campaigned on lowering drug costs and today he’s doing just that,” mentioned FTC spokesperson Joe Simonson.
Kennedy lauded Trump’s govt order, saying he “never thought that this would happen in my lifetime” and mentioned the coverage was the “fulcrum of Bernie Sanders’ runs for presidency [in 2016 and 2020].”
Former President Joe Biden had nixed Trump’s “most favored nation” coverage from his first time period. Trump chided that his predecessor did so “without any knowledge of what he was doing” and ripped the new drug pricing system that Biden pursued beneath the Inflation Reduction Act.
